Rego Payment Architectures (RPMT) 10-Q12 May 142014 Q1 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 31, 2014	1-May-14
Document and Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Mar-14	'
Entity Registrant Name	'VIRTUAL PIGGY, INC.	'
Entity Central Index Key	'0001437283	'
Current Fiscal Year End Date	'--12-31	'
Document Fiscal Period Focus	'Q1	'
Document Fiscal Year Focus	'2014	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	116,589,055

Balance_Sheets

Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
CURRENT ASSETS	'	'
Cash and cash equivalents	$4,108,065	$1,752,461
Accounts Receivable	1,285	1,000
Insurance receivable	'	4,325
Prepaid expenses	280,526	220,908
TOTAL CURRENT ASSETS	4,389,876	1,978,694
PROPERTY AND EQUIPMENT	'	'
Computer equipment	93,654	89,021
Furniture and fixtures	83,981	57,238
Leasehold improvements	8,350	'
Gross property and equipment	185,985	146,259
Less: accumulated depreciation	-46,016	-41,544
Total property and equipment	139,969	104,715
OTHER ASSETS	'	'
Deposit	346,949	118,118
Patents and trademarks, net of accumulated amortization of $52,258 and $42,129	784,152	739,657
Total other assets	1,131,101	857,775
TOTAL ASSETS	5,660,946	2,941,184
CURRENT LIABILITIES	'	'
Accounts payable and accrued expenses	1,596,488	2,149,681
Embedded derivative liability	3,834,200	'
Notes payable, net of discount of $0 and $86,087	'	913,913
TOTAL CURRENT LIABILITIES	5,430,688	3,063,594
CONTINGENCIES	'	'
STOCKHOLDERS' EQUITY	'	'
Preferred stock, $.0001 par value; 2,000,000 shares authorized; 50,450 shares issued and outstanding at March 31, 2014 and none issued and outstanding at December 31, 2013	5	'
Common stock, $ .0001 par value; 180,000,000 shares authorized; 116,589,055 and 111,396,768 shares issued and outstanding at March 31, 2014 and December 31, 2013	11,659	11,140
Additional paid in capital	43,820,350	35,318,751
Deficit accumulated during the development stage	-43,582,321	-35,450,446
Cumulative translation adjustment	-19,435	-1,855
STOCKHOLDERS' EQUITY	230,258	-122,410
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$5,660,946	$2,941,184

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Balance Sheets [Abstract]	'	'
Patents and trademarks, accumulated amoritization	$52,258	$42,129
Debt discount	'	$86,087
Preferred stock, par value per share	$0.00	$0.00
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	50,450	'
Preferred stock, shares outstanding	50,450	'
Common stock, par value per share	$0.00	$0.00
Common stock, shares authorized	180,000,000	180,000,000
Common stock, shares issued	116,589,055	111,396,768
Common stock, shares outstanding	116,589,055	111,396,768

Statements_of_Operations

Statements of Operations (USD $)	3 Months Ended		74 Months Ended
Statements of Operations (USD $)	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Statements of Operations [Abstract]	'	'	'
SALES	$425	$88	$8,020
OPERATING EXPENSES	'	'	'
Sales and marketing	1,197,412	894,647	11,278,549
Product development	885,974	461,385	6,127,836
Integration and customer support	187,039	119,197	1,366,490
General and administrative	1,217,303	1,035,071	12,634,642
Strategic Consulting	'	176,794	7,019,422
Total operating expenses	3,487,728	2,687,094	38,426,939
NET OPERATING LOSS	-3,487,303	-2,687,006	-38,418,919
OTHER INCOME (EXPENSE)	'	'	'
Interest income	1,502	3,489	20,888
Interest expense	-94,280	'	-632,496
Embedded Derivative Gain Loss On Embedded Derivative Net	-2,185,375	'	-2,185,375
Total other income (expense)	-2,278,153	3,489	-2,796,983
NET LOSS	-5,765,456	-2,683,517	-41,215,902
Less: Deemed dividend distributions	-2,366,419	'	-2,366,419
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	($8,131,875)	($2,683,517)	($43,582,321)
BASIC AND DILUTED NET LOSS PER COMMON SHARE	($0.07)	($0.03)	'
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING	114,818,293	101,792,509	'

Statements_of_Comprehensive_Lo

Statements of Comprehensive Loss (USD $)	3 Months Ended		74 Months Ended
Statements of Comprehensive Loss (USD $)	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Statements of Comprehensive Loss [Abstract]	'	'	'
NET LOSS	($5,765,456)	($2,683,517)	($41,215,902)
OTHER COMPREHENSIVE LOSS	'	'	'
Foreign Currency Translation Adjustments, net of tax	-17,580	'	-19,435
TOTAL OTHER COMPREHENSIVE LOSS, net of tax	-17,580	'	-19,435
COMPREHENSIVE LOSS	($5,783,036)	($2,683,517)	($41,235,337)

Statement_of_Changes_in_Stockh

Statement of Changes in Stockholders' Equity (Deficit) (USD $)	Total	Preferred Stock [Member]	Common Stock [Member]	Common Stock Subscribed [Member]	Common Stock Subscription Receivable [Member]	Additional Paid-In Capital [Member]	Deficit Accumulated During the Development Stage [Member]	Cumulative Translation Adjustment [Member]
Balance, values at Feb. 10, 2008	'	'	'	'	'	'	'	'
Balance, shares at Feb. 10, 2008	'	'	'	'	'	'	'	'
Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share, values	1,900	'	1,900	'	'	17,100	'	'
Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share, shares	'	'	19,000,000	'	'	'	'	'
Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit, values	250,000	'	714	'	'	249,286	'	'
Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit, shares	'	'	7,142,858	'	'	'	'	'
Employee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values	8,825	'	'	'	'	8,825	'	'
Nonemployee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values	107,859	'	'	'	'	107,859	'	'
Exercise of options on May 8, 2008, at $.04 per share, values	20,000	'	50	'	'	19,950	'	'
Exercise of options on May 8, 2008, at $.04 per share, shares	'	'	500,000	'	'	'	'	'
Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit, values	232,500	'	665	'	'	231,835	'	'
Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit, shares	'	'	6,642,858	'	'	'	'	'
Options issued for services in June 2008, vested immediately and valued at $.07 per share, values	395,567	'	'	'	'	395,467	'	'
Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share, values	918	'	'	'	'	918	'	'
Issuance of shares of common stock to investors in August 2008 at $1.00 per share, values	2,560	'	'	'	'	2,560	'	'
Issuance of shares of common stock to investors in August 2008 at $1.00 per share, shares	'	'	2,560	'	'	'	'	'
Exercise of options in September 2008 at $.04 per share, values	70,000	'	175	'	'	69,825	'	'
Exercise of options in September 2008 at $.04 per share, shares	'	'	1,750,000	'	'	'	'	'
Exercise of warrants in September 2008 at $.04 per share, values	10,000	'	25	'	'	9,975	'	'
Exercise of warrants in September 2008 at $.04 per share, shares	'	'	250,000	'	'	'	'	'
Net loss	-983,886	'	'	'	'	'	-983,886	'
Balance, values at Dec. 31, 2008	133,243	'	3,529	'	'	1,113,600	-983,886	'
Balance, shares at Dec. 31, 2008	'	'	35,288,276	'	'	'	'	'
Nonemployee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values	37,506	'	'	'	'	37,506	'	'
Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share, values	636	'	'	'	'	636	'	'
Exercise of options on January 26, 2009 at $.04 per share, values	40,000	'	100	'	'	39,900	'	'
Exercise of options on January 26, 2009 at $.04 per share, shares	'	'	1,000,000	'	'	'	'	'
Issuance of shares of common stock on April 7, 2009 at $1.00 per share, values	400,000	'	40	'	'	399,960	'	'
Issuance of shares of common stock on April 7, 2009 at $1.00 per share, shares	'	'	400,000	'	'	'	'	'
Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share, values	200,000	'	10	'	'	199,960	'	'
Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share, shares	'	'	100,000	'	'	'	'	'
Exercise of options on July 30, 2009 at $.04 per share, values	40,000	'	100	'	'	39,900	'	'
Exercise of options on July 30, 2009 at $.04 per share, shares	'	'	1,000,000	'	'	'	'	'
Nonemployee options issued for services on August 18, 2009 vested immediately and valued at $.31 per share, values	10,462	'	'	'	'	10,462	'	'
Exercise of warrants on August 21, 2009 at $.04 per share, values	40,000	'	100	'	'	39,900	'	'
Exercise of warrants on August 21, 2009 at $.04 per share, shares	'	'	1,000,000	'	'	'	'	'
Exercise of options on September 2, 2009 at $.04 per share, values	20,000	'	50	'	'	19,950	'	'
Exercise of options on September 2, 2009 at $.04 per share, shares	'	'	500,000	'	'	'	'	'
Issuance of shares of common stock on September 17, 2009 at $1.00 per share, values	100,000	'	10	'	'	99,990	'	'
Issuance of shares of common stock on September 17, 2009 at $1.00 per share, shares	'	'	100,000	'	'	'	'	'
Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share, values	1,080,427	'	108	'	'	1,080,319	'	'
Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share, shares	'	'	1,080,427	'	'	'	'	'
Issuance of shares of common stock on October 16, 2009 at $1.00 per share, values	100,000	'	10	'	'	99,990	'	'
Issuance of shares of common stock on October 16, 2009 at $1.00 per share, shares	'	'	100,000	'	'	'	'	'
Exercise of warrants on October 22, 2009 at $.04 per share, values	40,000	'	100	'	'	39,900	'	'
Exercise of warrants on October 22, 2009 at $.04 per share, shares	'	'	1,000,000	'	'	'	'	'
Exercise of warrants on December 2, 2009 at $.04 per share, values	40,000	'	100	'	'	39,900	'	'
Exercise of warrants on December 2, 2009 at $.04 per share, shares	'	'	1,000,000	'	'	'	'	'
Exercise of options on December 10, 2009 at $.04 per share, values	10,000	'	25	'	'	9,975	'	'
Exercise of options on December 10, 2009 at $.04 per share, shares	'	'	250,000	'	'	'	'	'
Exercise of warrants on December 31, 2009 at $.04 per share, values	40,000	'	100	'	'	39,900	'	'
Exercise of warrants on December 31, 2009 at $.04 per share, shares	'	'	1,000,000	'	'	'	'	'
Stock issuance costs	-65,000	'	'	'	'	-65,000	'	'
Net loss	-2,236,476	'	'	'	'	'	-2,236,476	'
Balance, values at Dec. 31, 2009	30,798	'	4,382	'	'	3,246,778	-3,220,362	'
Balance, shares at Dec. 31, 2009	'	'	43,818,703	'	'	'	'	'
Nonemployee options issued for services on August 18, 2009 vested immediately and valued at $.31 per share, values	27,899	'	'	'	'	27,899	'	'
Exercise of options on January 5, 2010 at $.04 per share, values	40,000	'	100	'	'	39,900	'	'
Exercise of options on January 5, 2010 at $.04 per share, shares	'	'	1,000,000	'	'	'	'	'
Exercise of warrant on February 22, 2010 at $.04 per share, values	35,713	'	89	'	'	35,624	'	'
Exercise of warrant on February 22, 2010 at $.04 per share, shares	'	'	892,858	'	'	'	'	'
Exercise of warrants in March 2010 at $.04 per share, values	40,000	'	100	'	'	39,900	'	'
Exercise of warrants in March 2010 at $.04 per share, shares	'	'	1,000,000	'	'	'	'	'
Exercise of warrants in April 2010 at $.04 per share, values	100,000	'	250	'	'	99,750	'	'
Exercise of warrants in April 2010 at $.04 per share, shares	'	'	2,500,000	'	'	'	'	'
Issuance of shares of common stock in conjunction with notes payable in May through August 2010, values	400,742	'	48	'	'	400,694	'	'
Issuance of shares of common stock in conjunction with notes payable in May through August 2010, shares	'	'	483,750	'	'	'	'	'
Issuance of shares of common stock for retirement of 400,000 options at $.25 per share, values	'	'	6	'	'	-6	'	'
Issuance of shares of common stock for retirement of 400,000 options at $.25 per share, shares	'	'	65,000	'	'	'	'	'
Issuance of share of common stock from August through December 2010 through private placement at $.20 per share, values	1,925,000	'	963	'	'	1,924,037	'	'
Issuance of share of common stock from August through December 2010 through private placement at $.20 per share, shares	'	'	9,625,000	'	'	'	'	'
Issuance of shares of common stock on November 1, 2010 for conversion of notes payable at $.20 per share, values	75,000	'	38	'	'	74,962	'	'
Issuance of shares of common stock on November 1, 2010 for conversion of notes payable at $.20 per share, shares	'	'	375,000	'	'	'	'	'
Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share, values	100,000	'	11	'	'	99,989	'	'
Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share, shares	'	'	111,111	'	'	'	'	'
Exercise of options on December 2, 2010 at $.04 per share, values	120,000	'	300	'	'	119,700	'	'
Exercise of options on December 2, 2010 at $.04 per share, shares	'	'	3,000,000	'	'	'	'	'
Exercise of warrants in December 2010 at $.04 per share, values	100,000	'	250	'	'	99,750	'	'
Exercise of warrants in December 2010 at $.04 per share, shares	'	'	2,500,000	'	'	'	'	'
Nonemployee options issued for services from August through November 2010 vested immediately and valued at $.01 per share, values	13,816	'	'	'	'	13,816	'	'
Net loss	-1,489,190	'	'	'	'	'	-1,489,190	'
Balance, values at Dec. 31, 2010	1,519,778	'	6,537	'	'	6,222,793	-4,709,552	'
Balance, shares at Dec. 31, 2010	'	'	65,371,422	'	'	'	'	'
Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share, values	49,000	'	10	'	'	48,990	'	'
Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share, shares	'	'	100,000	'	'	'	'	'
Issuance of shares of common stock in conjunction with notes payable from September through December 2011, value	82,665	'	15	'	'	82,650	'	'
Issuance of shares of common stock in conjunction with notes payable from September through December 2011, shares	'	'	150,000	'	'	'	'	'
Issuance of shares of common stock and 625,000 warrants on December 20, 2011 through private placement at $.80 per unit, values	500,000	'	125	'	'	499,875	'	'
Issuance of shares of common stock and 625,000 warrants on December 20, 2011 through private placement at $.80 per unit, shares	'	'	1,250,000	'	'	'	'	'
Issuance of warrants in conjunction with notes payable from September through December 2011	20,930	'	'	'	'	20,930	'	'
Fair value of revalued warrants at $.09 to $.76 per share	88,601	'	'	'	'	88,601	'	'
Nonemployee options issued for services from August through November 2010 vested immediately and valued at $.01 per share, values	'	'	'	'	'	3,146	'	'
Nonemployee options issued for services on January 24, 2011, vested immediately and valued at $.20 per share	46,019	'	'	'	'	46,019	'	'
Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share	52,243	'	'	'	'	52,243	'	'
Net loss	-2,724,796	'	'	'	'	'	-2,724,796	'
Balance, values at Dec. 31, 2011	-362,414	'	6,687	'	'	7,065,247	-7,434,348	'
Balance, shares at Dec. 31, 2011	'	'	66,871,422	'	'	'	'	'
Stock issuance costs	-28,000	'	'	'	'	-28,000	'	'
Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, values	7,086,932	'	2,044	'	'	7,084,888	'	'
Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, shares	'	'	204,426,948	'	'	'	'	'
Issuance of shares of common stock and 1,500,000 warrants through December 31, 2012 through private placement at $.80 per unit, values	1,050,000	'	262	'	'	1,049,738	'	'
Issuance of shares of common stock and 1,500,000 warrants through December 31, 2012 through private placement at $.80 per unit, shares	'	'	2,625,000	'	'	'	'	'
Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, values	3,312,537	'	136	'	'	3,312,401	'	'
Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, shares	'	'	1,363,185	'	'	'	'	'
Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, values	200,000	'	57	'	'	199,943	'	'
Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, shares	'	'	571,428	'	'	'	'	'
Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, values	297,500	'	35	'	'	297,465	'	'
Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, shares	'	'	350,000	'	'	'	'	'
Issuance of shares of common stock through December 31, 2012 through private placement at $.70 per share, values	5,560,000	'	794	'	'	5,559,206	'	'
Issuance of shares of common stock through December 31, 2012 through private placement at $.70 per share, shares	'	'	7,942,858	'	'	'	'	'
Issuance of shares of common stock through December 31, 2012 through private placement at $.75 per share, values	500,000	'	67	'	'	499,933	'	'
Issuance of shares of common stock through December 31, 2012 through private placement at $.75 per share, shares	'	'	666,667	'	'	'	'	'
Exercise of options on April 10, 2012 at $.04 per share, values	10,000	'	25	'	'	9,975	'	'
Exercise of options on April 10, 2012 at $.04 per share, shares	'	'	250,000	'	'	'	'	'
Exercise of options on May 25, 2012 at $.04 per share, values	14,000	'	35	'	'	13,965	'	'
Exercise of options on May 25, 2012 at $.04 per share, shares	'	'	350,000	'	'	'	'	'
Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share, values	2,219	'	'	'	'	2,219	'	'
Nonemployee options issued for services from January through December 2012, vested immediately and valued from $.11 to $.95 per share, values	759,292	'	'	'	'	759,292	'	'
Nonemployee options issued for services on January 2012 through December 2012, vesting over three years and valued at$. 17 to $.40 per share, values	39,751	'	'	'	'	39,751	'	'
Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $.11 To $.53 per share, values	283,460	'	'	'	'	283,460	'	'
Employee options issued for services from January 2012 through December 2012, vesting immediately and valued at $.14 to $.42 per share, values	150,631	'	'	'	'	150,631	'	'
Common stock subscription for 62,500 units through private placement at $.80 per unit	'	'	'	50,000	-50,000	'	'	'
Net loss	-12,039,726	'	'	'	'	'	-12,039,726	'
Balance, values at Dec. 31, 2012	6,836,182	'	10,142	50,000	-50,000	26,300,114	-19,474,074	'
Balance, shares at Dec. 31, 2012	'	'	101,417,508	'	'	'	'	'
Stock issuance costs	-395,221	'	'	'	'	-395,221	'	'
Nonemployee options issued for services from January through December 2012, vested immediately and valued from $.11 to $.95 per share, values	34,372	'	'	'	'	34,372	'	'
Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, values	50,000	'	13	'	'	49,987	'	'
Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, shares	'	'	125,000	'	'	'	'	'
Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, values	850,000	'	113	'	'	849,887	'	'
Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, shares	'	'	1,133,334	'	'	'	'	'
Issuance of shares on April 15, 2013 common stock for services, values	49,071	'	3	'	'	49,068	'	'
Issuance of shares on April 15, 2013 common stock for services, shares	'	'	26,521	'	'	'	'	'
Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, value	5,170,595	'	287	'	'	5,170,308	'	'
Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, shares	'	'	2,872,553	'	'	'	'	'
Fair value of warrants issued with notes payable	92,469	'	'	'	'	92,469	'	'
Fair value of revalued warrants at $0.78 per share	6,540	'	'	'	'	6,540	'	'
Fair value of revalued options $1.07 per share	1,199	'	'	'	'	1,199	'	'
Exercise of options at $0.04 per share in May 2013, value	30,000	'	75	'	'	29,925	'	'
Exercies of options at $0.04 per share in May 2013, shares	'	'	750,000	'	'	'	'	'
Exercise of options at $0.35 per share on May 14, 2013, value	105,000	'	30	'	'	104,970	'	'
Exercise of options at $0.35 per share on May 14, 2013, shares	'	'	300,000	'	'	'	'	'
Exercise of options at $0.75 per share in May 2013, value	50,000	'	7	'	'	49,993	'	'
Exercise of options at $0.75 per share in May 2013, shares	'	'	66,667	'	'	'	'	'
Exercise of warrants at $0.04 per share on May 26, 2013, value	80,000	'	200	'	'	79,800	'	'
Exercise of warrants at $0.04 per share on May 26, 2013, shares	'	'	2,000,000	'	'	'	'	'
Exercise of warrants at $0.50 per share in May through August 2013, value	1,352,593	'	270	'	'	1,352,323	'	'
Exercise of warrants at $0.50 per share in May through August 2013, shares	'	'	2,705,185	'	'	'	'	'
Nonemployee options/warrants issued for services from January 2013 through December 2013, vested immediately to 3 years and valued from $0.09 to $1.66 per share	784,247	'	'	'	'	784,247	'	'
Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $0.11 to $0.80 per share	447,975	'	'	'	'	447,975	'	'
Employee options issued for services on January 2013 through December 30, 2013, vesting over three years and valued at $0.22 to $0.68 per share	310,795	'	'	'	'	310,795	'	'
Common stock subscription for 62,500 units through private placement at $.80 per unit	'	'	'	-50,000	50,000	'	'	'
Net loss	-15,976,372	'	'	'	'	'	-15,976,372	'
Cumulative translation adjustment	-1,855	'	'	'	'	'	'	-1,855
Balance, values at Dec. 31, 2013	-122,410	'	11,140	'	'	35,318,751	-35,450,446	-1,855
Balance, shares at Dec. 31, 2013	111,396,768	'	111,396,768	'	'	'	'	'
Stock issuance costs	-170,165	'	'	'	'	-170,165	'	'
Issuance of shares of convertible preferred stock and 5,045,000 warrants through March 31, 2014, through private placement at $1.00 per unit	3,396,175	5	'	'	'	3,396,170	'	'
Issuance of shares of convertible preferred stock and 5,045,000 warrants through March 31, 2014, through private placement at $1.00 per unit, shares	'	50,450	'	'	'	'	'	'
Issuance of shares of common stock from exercise of warrants through warrant exchange offering at $.50 per share	2,521,143	'	504	'	'	2,520,639	'	'
Issuance of shares of common stock from exercise of warrants through warrant exchange offering at $.50 per share, shares	'	'	5,042,287	'	'	'	'	'
Exercise of warrants at $0.50 per share in March 2014, value	25,000	'	5	'	'	24,995	'	'
Exercise of warrants at $0.50 per share in March 2014, shares	'	'	50,000	'	'	'	'	'
Exercise of options at $0.75 per share in March 2014, value	75,000	'	10	'	'	74,990	'	'
Exercise of options at $0.75 per share in March 2014, shares	'	'	100,000	'	'	'	'	'
Fair value of revalued warrants at $0.22 to$ 0.76 per share	9,228	'	'	'	'	9,228	'	'
Nonemployee options issued for services from January 2012 through December 2012, vested over 3 years and valued from $1.11 to $1.55 per share	6,335	'	'	'	'	6,335	'	'
Nonemployee options/warrants issued for services from January 2013 through December 2013, vested immediately to 3 years and valued from $1.04 to $3.05 per share	43,112	'	'	'	'	43,112	'	'
Employee options issued for services from January 2012 through December 2013, vested over 3 years and valued from $0.50 to $0.92 per share	201,494	'	'	'	'	201,494	'	'
Employee options issued for services on January 2014 through March 31, 2014, vesting over two to three years and valued at $1.05 to $1.43 per share	28,382	'	'	'	'	28,382	'	'
Deemed dividend distribution in conjunction with Preferred Series A offering	'	'	'	'	'	1,648,825	-1,648,825	'
Deemed dividend distribution in conjunction with warrant exchange offering	'	'	'	'	'	717,594	-717,594	'
Net loss	-5,765,456	'	'	'	'	'	-5,765,456	'
Cumulative translation adjustment	-17,580	'	'	'	'	'	'	-17,580
Balance, values at Mar. 31, 2014	$230,258	$5	$11,659	'	'	$43,820,350	($43,582,321)	($19,435)
Balance, shares at Mar. 31, 2014	116,589,055	50,450	116,589,055	'	'	'	'	'

Statement_of_Changes_in_Stockh1

Statement of Changes in Stockholders' Equity (Deficit) (Parenthetical) (USD $)

5 Months Ended

11 Months Ended

12 Months Ended

3 Months Ended

5 Months Ended

6 Months Ended

11 Months Ended

12 Months Ended

3 Months Ended

11 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

4 Months Ended

11 Months Ended

12 Months Ended

2 Months Ended

12 Months Ended

2 Months Ended

12 Months Ended

11 Months Ended

12 Months Ended

11 Months Ended

12 Months Ended

11 Months Ended

12 Months Ended

11 Months Ended

3 Months Ended

11 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

Dec. 31, 2010

Dec. 31, 2008

Dec. 31, 2009

Mar. 31, 2013

Sep. 30, 2008

Jun. 30, 2012

Dec. 31, 2008

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Mar. 31, 2014

Dec. 31, 2008

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Nov. 30, 2010

Dec. 31, 2008

Dec. 31, 2011

Dec. 31, 2009

Aug. 31, 2011

Dec. 31, 2012

Aug. 31, 2011

Dec. 31, 2012

Dec. 31, 2008

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2012

Dec. 31, 2009

Dec. 31, 2012

Dec. 31, 2008

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2013

Dec. 31, 2009

Dec. 31, 2008

Mar. 31, 2014

Dec. 31, 2008

Dec. 31, 2013

Dec. 31, 2010

Dec. 31, 2009

Mar. 31, 2014

Dec. 31, 2010

Dec. 31, 2009

Mar. 31, 2014

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2010

Dec. 31, 2012

Dec. 31, 2010

Dec. 31, 2012

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2012

Mar. 31, 2014

Dec. 31, 2012

Dec. 31, 2013

Issuance of Shares of Common Stock [Member]

Issuance of Shares of Common Stock Two [Member]

Issuance Of Shares Of Common Stock Three [Member]

Issuance Of Shares Of Common Stock Four [Member]

Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]

Issuance of Shares of Preferred Stock and Warrants Through Private Placement [Member]

Employee Options Issued for Services Transaction One [Member]

Employee Options Issued for Services Transaction Two [Member]

Nonemployee Options Issued for Services Transaction One [Member]

Nonemployee Options Issued for Services Transaction Two [Member]

Nonemployee Options Issued For Services Transaction Three [Member]

Exercise of Options Transaction One [Member]

Exercise of Options Transaction Two [Member]

Exercise of Options Transaction Three [Member]

Exercise Of Options Transaction Four [Member]

Options Issued for Services [Member]

Issuance of Shares of Common Stock to Investors [Member]

Exercise of Warrants Transaction One [Member]

Exercise of Warrants Transaction Two [Member]

Exercise Of Warrants Transaction Four [Member]

Exercise Of Warrants Transaction Three [Member]

Issuance of Shares of Common Stock for Future Services [Member]

Issuance of Shares of Common Stock for Retirement of Options [Member]

Issuance of Shares of Common Stock Through Private Placement Transaction One [Member]

Issuance of Shares of Common Stock Through Private Placement Transaction Two [Member]

Issuance of Shares of Common Stock for Conversion of Notes Payable [Member]

Issuance of Shares of Common Stock and Warrants to Discharge Notes Payable and Accrued Interest [Member]

Issuance of Shares of Common Stock with Respect to Settlement Agreement [Member]

Common Stock Subscription for Units Through Private Placement [Member]

Nonemployee Options/Warrants Issued for Services [Member]

Fair Value of Revalued Warrants [Member]

Nonemployee Options And Warrants Issued For Services Two [Member]

Fair Value of Revalued Options [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Equity issuance date

11-Feb-08

7-Apr-09

29-Jun-09

17-Sep-09

16-Oct-09

20-Dec-11

3-Mar-08

24-Jan-11

18-Aug-09

19-Jun-08

18-Aug-09

8-Mar-08

19-Jun-08

8-May-08

10-Apr-12

5-Jan-10

26-Jan-09

14-May-13

25-May-12

2-Dec-10

30-Jul-09

2-Sep-09

10-Dec-09

26-May-13

22-Feb-10

21-Aug-09

31-Dec-09

2-Dec-09

21-May-12

1-Jun-11

19-Nov-10

9-Oct-09

1-Nov-10

Equity issuance date by month and year

'2008-02

'2013-05

'2008-09

'2013-05

'2008-06

'2008-08

'2008-09

'2014-03

'2010-03

'2014-03

'2010-12

'2010-04

Equity issuance, number securities issued for cash

19,000,000

614,286

10,213,474

14,285,716

1,436,277

1,500,000

625,000

285,714

Equity issuance, price or exercise price per security issued

$0.20

$0.00

$0.80

$0.75

$0.70

$0.04

$1.80

$0.80

$0.02

$0.22

$0.11

$0.68

$0.53

$0.50

$0.14

$0.92

$0.42

$0.01

$0.02

$0.20

$0.31

$0.10

$0.11

$0.19

$0.95

$0.01

$0.31

$0.02

$0.17

$0.40

$0.01

$1.11

$1.55

$0.04

$0.35

$0.04

$0.75

$0.04

$0.07

$0.50

$0.04

$0.50

$0.04

$0.75

$0.04

$2.43

$0.49

$0.90

$0.25

$0.70

$0.75

$0.20

$0.70

$0.85

$0.80

$0.09

$1.66

$0.78

$0.22

$0.09

$0.76

$1.04

$3.05

$0.34

$1.07

Retirement of options, shares

400,000

Units subscribed

62,500

Number of shares entitled by warrants

5,045,000

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	3 Months Ended		74 Months Ended
Statements of Cash Flows (USD $)	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES	'	'	'
NET LOSS	($5,765,456)	($2,683,517)	($41,215,902)
Adjustments to reconcile net loss to net cash used in operating activities	'	'	'
Fair value of warrants issued in exchange for services	'	'	638,516
Fair value of options issued in exchange for services	288,551	191,494	3,263,914
Fair value of stock issued in exchange for services	'	'	4,791,035
Change in fair value of embedded derivative liability	2,185,375	'	2,185,375
Amortization of deferred costs	'	'	78,243
Accretion of discount on notes payable	86,087	'	518,565
Depreciation and amortization	18,518	11,671	108,417
Provision for bad debt	'	'	42,768
Loss on disposal of fixed assets	8,109	'	16,942
(Increase) decrease in assets	'	'	'
Accounts receivable	-285	-88	-1,285
Insurance receivable	4,325	75,000	'
Other receivable	'	'	-42,768
Prepaid expenses	-59,618	-3,464	-280,526
Deposits	-228,831	-8,900	-346,949
Increase (decrease) in liabilities	'	'	'
Accounts payable, accrued expenses and litigation settlement	-553,194	-301,789	1,918,987
Net cash used in operating activities	-4,016,419	-2,719,593	-28,324,668
CASH FLOWS FROM INVESTING ACTIVITIES	'	'	'
Purchase of equipment	-51,751	-22,867	-213,068
Patent and trademark costs	-54,624	-91,745	-836,411
Net cash used in investing activities	-106,375	-114,612	-1,049,479
CASH FLOWS FROM FINANCING ACTIVITIES	'	'	'
Proceeds from note payable - stockholders	'	'	1,747,500
Repayment of note payable - stockholders	-1,000,000	'	-1,572,500
Proceeds from notes payable	'	'	75,000
Proceeds from issuance of preferred stock and warrants	5,045,000	'	5,045,000
Proceeds from issuance of common stock	'	900,000	23,796,584
Proceeds from exercise of options	75,000	'	644,000
Proceeds from exercise of warrants	2,546,143	'	4,424,449
Stock issuance costs	-170,165	-60,783	-658,386
Net cash provided by financing activities	6,495,978	839,217	33,501,647
EFFECT OF EXCHANGE RATE ON CASH	-17,580	'	-19,435
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	2,355,604	-1,994,988	4,108,065
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	1,752,461	7,371,036	'
CASH AND CASH EQUIVALENTS - END OF PERIOD	4,108,065	5,376,048	4,108,065
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES:	'	'	'
Income taxes paid	'	'	'
Interest paid	8,193	'	2,498
Fair value of common stock issued as discount for notes payable	'	'	483,409
Conversion of notes payable and accrued interest into common stock	'	'	275,000
Fair value of warrants issued as discount for notes payable	'	'	20,930
Issuance of common stock for settlement of payable	'	'	297,500
Fair value of beneficial conversion value as discount against Preferred Stock	1,648,825	'	1,648,825
Fair value of warrant liability as discount against Preferred Stock	1,547,925	'	1,547,925
Accretion of discount on preferred stock as deemed distribution	1,648,825	'	1,648,825
Deemed dividend distribution in conjunction with warrant exchange offering	$717,594	'	$717,594

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Mar. 31, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	Nature of the Business
	Virtual Piggy, Inc. ("the Company") is a development stage enterprise incorporated in the state of Delaware on February 11, 2008. Virtual Piggy is a technology company that delivers an online ecommerce solution for the family. Its system allows parents and their children to manage, allocate funds and track their expenditures, savings and charitable giving online. Its system is designed to allow the child to transact online without a credit card by gaining the parent's permission ahead of time and allowing the parent to set up the rules of use and authorized spending limits. Our principal office is located in Hermosa Beach, California and in 2013 we opened an office in London, England to support the sales and marketing efforts in Europe and the development of our mobile applications.

	The Oink (formerly Virtual Piggy) service enables online businesses to interact and transact with the "Under 18" market in a manner consistent with the Children's Online Privacy Protection Act ("COPPA") and other similar international children's privacy laws. Oink was launched in the US in 2012 and in the European market in 2013, and now has the capability to offer and deliver gift cards.

	We secure agreements with merchants, retail and gaming e-commerce platforms and payment processors, which allow us to offer our Oink service to our user base. Over 20 retailers and gaming companies are using Oink with their e-commerce systems and the Company is in the process of integrating the other signed retailers and gaming companies. The Company is continuing to add merchants. To date, the Company has over 1 million users of its system. The Company defines a system user as a registered account that has accessed the Oink service within the past 12 months.

	Basis of Presentation
	The financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 915 for development stage entities. The accompanying unaudited financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions for Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States ("U.S. GAAP") for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The financial statements should be read in conjunction with the financial statements and notes included in the Company's Annual Report on form 10-K for the year ended December 31, 2013 as filed with the Securities and Exchange Commission (the "SEC"). Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ended December 31, 2014.

	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

	Comprehensive Income
	The Company follows FASB ASC 220 in reporting comprehensive income. Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income. The Company has one item of other comprehensive loss, consisting of a foreign translation adjustment.

	Fair Value of Financial Instruments
	The Company's financial instruments consist of accounts receivable, accounts payable and accrued expenses, embedded derivative and warrant liability. The carrying value of accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short maturities.

	The Company follows FASB ASC 820, Fair Value Measurements and Disclosures, and applies it to all assets and liabilities that are being measured and reported on a fair value basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

	Level 1: Quoted market prices in active markets for identical assets or liabilities

	Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data

	Level 3: Unobservable inputs that are not corroborated by market data

	The level in the fair value within which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.

	Foreign Currency Translation
	The functional currency of operations outside the U.S. is British Pounds.

	Concentration of Credit Risk Involving Cash
	The Company may have deposits with a financial institution which at times exceed Federal Depository Insurance ("FDIC") coverage. The Company has not experienced any losses from maintaining cash accounts in excess of federally insured limits.

	Cash and Cash Equivalents
	For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents.

	Property and Equipment
	Property and equipment is stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, principally three to seven years. Maintenance and repairs of property are charged to operations, and major improvements are capitalized. Upon retirement, sale, or other disposition of property and equipment, the costs and accumulated depreciation are eliminated from the accounts, and any resulting gain or loss is included in operations. Depreciation of property and equipment was $8,389 and $5,875 for the three months ended March 31, 2014 and 2013 and is included in general and administrative expenses.

	Patents and Trademarks
	The Company has one issued patent with the United States Patent and Trademark Office ("USPTO"), entitled Systems and Method for Verifying the Age of an Internet User, and filed for nine provisional patents. Additionally, the Company has been issued two patents in Germany, entitled Virtual Piggy Bank and Parent Match, while the remaining patents in Germany are still pending. The Company also has patents pending in Australia, Brazil, Canada and Europe under the Patent Cooperation Treaty ("PCT"). Costs associated with the registration and legal defense of the patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents which were determined to be 20 years.

	Long-Lived Assets
	The Company evaluates the recoverability of its long-lived assets in accordance with FASB ASC 360 "Property, Plant, and Equipment." The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets are measured by a comparison of the carrying amount of an asset to future cash flows expected to be generated by the asset, undiscounted and without interest or independent appraisals. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the assets.

	Revenue Recognition
	In accordance with Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 104, Revenue Recognition (Codified in FASB ASC 605), the Company will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, the Company will generally recognize revenue at the time of the sale of the associated product.

	Income Taxes
	The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. Tax years from 2010 through 2013 remain subject to examination by major tax jurisdictions.

	Stock-based Payments
	The Company accounts for stock-based compensation under the provisions of FASB ASC 718, Compensation-Stock Compensation which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC 505 -50, Equity-Based Payments to Non-Employees ("ASC 505-50"). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid-in capital in stockholders' equity over the applicable service periods.

	Advertising Costs
	Advertising costs are expensed as incurred. Advertising costs were $53,628 and $222,847 for the three months ended March 31, 2014 and 2013 and are included in sales and marketing expenses.

	Research and Development Costs
	In accordance with FASB ASC 730, research and development costs are expensed when incurred. Research and development costs for the three months ended March 31, 2014 and 2013 were $852,744 and $454,378.

Loss Per Share
The Company follows FASB ASC 260 when reporting Earnings Per Share resulting in the presentation of basic and diluted earnings per share. Because the Company reported a net loss for the three months ended March 31, 2014 and 2013, common stock equivalents, including preferred stock, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same.

Start-up Costs
In accordance with FASB ASC 720, start-up costs are expensed as incurred.

Segment Information
The Company is organized and operates as one operating segment. In accordance with FASB ASC 280, Segment Reporting, the chief operating decision-maker has been identified as the Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company subject to Board approval. Since the Company operates in one segment and provides one group of similar products, all financial segment and product line information required by FASB ASC 280 can be found in the consolidated financial statements.

Recently Adopted Accounting Pronouncements
As of March 31, 2014 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company's financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted
As of March 31, 2014, there were no recently issued accounting standards not yet adopted which would have a material effect on the Company's financial statements.

Reclassifications
Certain amounts in the 2013 and cumulative since inception statements of operations have been reclassified in order for them to be in conformity with the 2014 presentation.

MANAGEMENT_PLANS

MANAGEMENT PLANS	3 Months Ended
MANAGEMENT PLANS	Mar. 31, 2014
MANAGEMENT PLANS [Abstract]	'
MANAGEMENT PLANS	'
	NOTE 2 - MANAGEMENT PLANS

	The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant losses and experienced negative cash flow from operations during the development stage. These conditions raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

	Since inception, the Company has focused on developing and implementing its business plan. The Company believes that its existing cash resources will not be sufficient to sustain operations during the next twelve months. The Company currently needs to generate revenue in order to sustain its operations. In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities. The issuance of additional equity would result in dilution to existing shareholders. If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would likely be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations.

	The Company's current monetization model is to derive a percentage of all revenues generated by online merchants using the Oink service. Merchants are billed at the end of each month for all transactions that have been processed by the Company on their behalf in the prior month. As the merchant base and consumer base grows, and as the trend to higher online spending levels continues, the Company expects to generate additional revenue to support operations.

	If sufficient revenues are not generated to sustain operations or additional funding cannot be obtained in the short term, the Company will need to reduce monthly expenditures to a level that will enable the Company to continue until such funds can be obtained. For the three months ended March 31, 2014, and for the year ended December 31, 2013, the Company raised $7.5 million net of stock issuance costs of $0.2 million, and $8.3 million net of stock issuance costs of $0.4 million, respectively, through private placements of its equity securities and from exercises of warrants. Additionally, in April 2014, the Company raised an additional $5.8 million through a private placements of its equity securities.

	The Company is in the development stage at March 31, 2014. Successful completion of the Company's development program, and the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities and achieving a level of sales adequate to support the Company's cost structure. However, there can be no assurances that the Company will be able to secure additional equity investment or achieve an adequate sales level.

PATENTS

PATENTS	3 Months Ended
PATENTS	Mar. 31, 2014
PATENTS [Abstract]	'
PATENTS	'
	NOTE 3 - PATENTS AND TRADEMARKS

	The Company continues to apply for patents and purchased the Oink trademark in November 2013. Accordingly, costs associated with the registration of the patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents (20 years). The trademark is also being amortized on a straight-line basis over its estimated useful life of 20 years. At March 31, 2014 and December 31, 2013, capitalized patent and trademark costs were $784,152 and $739,657. Amortization expense for patents and trademarks was $10,129 and $5,265 for the three months ended March 31, 2014 and 2013.

NOTES_PAYABLE

NOTES PAYABLE	3 Months Ended
	Mar. 31, 2014
NOTES PAYABLE [Abstract]	'
NOTES PAYABLE	'
	NOTE 4 - NOTES PAYABLE

	On December 27, 2013, the Company entered into two identical agreements with two stockholders that each include a note payable in the amount of $500,000 and two-year warrants to purchase 37,500 shares of the Company's common stock at $0.01 and two-year warrants to purchase 50,000 shares of the Company's common stock at $1.00 per share. The note payable bears interest at 10% per annum and is payable upon the earlier of:

		a.	5 days after the sale of the Company's securities in one transaction or series of related transactions, which sale results in gross proceeds to the Company of at least $3 million;
		b.	Upon (i) the sale or other disposition of all or substantially all of the Company's assets or (ii) the acquisition of the Company by another entity by means of any transaction or series of related transactions to which the Company is a party other than a transaction or series of transactions in which the holders of the voting securities of the Company outstanding immediately prior to such transaction continue to retain, as a result of shares in the Company held by such holders prior to such transaction, at least 50% of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such transaction or series of transactions;
		c.	February 28, 2014.

	The warrants were valued at $92,470, fair value, using the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.2%, risk free interest rate of .4% and expected option life of 2 years. The warrant values were treated as a discount to the value of the note payable in accordance with FASB ASC 835-30-25, Recognition and are being accreted over the term of the note payable for financial statement purposes. These notes were repaid in full in January 2014 and therefore the remaining unamortized discount was fully accreted.

	During the three months ended March 31, 2014 and 2013, $86,087 and $0 of interest was accreted on the notes payable.

INCOME_TAXES

INCOME TAXES	3 Months Ended
INCOME TAXES	Mar. 31, 2014
INCOME TAXES [Abstract]	'
INCOME TAXES	'
	NOTE 5 - INCOME TAXES

	Income tax expense was $0 for the three months ended March 31, 2014 and 2013.

	As of December 31, 2013, the Company had net operating loss carry forwards approximating $39.7 million.

	As of January 1, 2014, the Company had no unrecognized tax benefits, and accordingly, the Company did not recognize interest or penalties during 2014 related to unrecognized tax benefits. There has been no change in unrecognized tax benefits during the three months ended March 31, 2014, and there was no accrual for uncertain tax positions as of March 31, 2014. Tax years from 2010 through 2013 remain subject to examination by major tax jurisdictions.

	There is no income tax benefit for the losses for the three months ended March 31, 2014 and 2013, since management has determined that the realization of the net tax deferred asset is not assured and has created a valuation allowance for the entire amount of such benefits.

LITIGATION_SETTLEMENT

LITIGATION SETTLEMENT	3 Months Ended
LITIGATION SETTLEMENT	Mar. 31, 2014
LITIGATION SETTLEMENT [Abstract]	'
LITIGATION SETTLEMENT	'
	NOTE 6 - LITIGATION SETTLEMENT

	The Company entered into a settlement agreement with an investor in 2012, whereby the Company agreed to pay the investor a settlement of $450,000 and the investor agreed to cease trading in the Company's stock and to return warrants issued to the investor. The Company's insurance carrier agreed to reimburse the Company with respect to this litigation. Both the settlement payment and the insurance company settlement were completed in 2013.

CONVERTIBLE_PREFERRED_STOCK

CONVERTIBLE PREFERRED STOCK	3 Months Ended
CONVERTIBLE PREFERRED STOCK	Mar. 31, 2014
CONVERTIBLE PREFERRED STOCK [Abstract]	'
CONVERTIBLE PREFERRED STOCK	'
	NOTE 7 - CONVERTIBLE PREFERRED STOCK

	In January 2014, the Company, pursuant to a Securities Purchase Agreement (the "Purchase Agreement"), issued to certain private investors 50,450 shares of the Company's Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") at an original issue price of $100 per share (the "Original Issue Price") and warrants to purchase 5,045,000 shares of the Company's common stock (the "Warrants") for an aggregate purchase price of $5,045,000. Pursuant to the Purchase Agreement, the Company also granted piggyback registration rights to the holders of the Preferred Stock and Warrants. The Purchase Agreement provides that the holders of the Preferred Stock shall be entitled to nominate two directors of the Company. Dividends accrue at a rate of 8% and are cumulative. As of December 31, 2013, the Company had incurred and capitalized approximately $131,000 of costs associated with this offering, which were charged to additional paid in capital in January 2014 when the transaction was consummated.

	In accordance with FASB ASC 480 and 815, the Preferred Stock has been classified as permanent equity and was valued at $3,396,175, net of the beneficial conversion feature of $1,648,825, at January 27, 2014.

	The conversion feature of the Preferred Stock is an embedded derivative, which is classified as a liability in accordance with FASB ASC 815 and was valued in accordance with FASB ASC 470 as a beneficial conversion feature at a fair market value of $1,648,825 at January 27, 2014 and $3,834,200 at March 31, 2014. This was classified as an embedded derivative liability and a discount to Preferred Stock. Since the preferred stock can be converted at any time, the full amount of the discount was accreted and reflected as a deemed distribution.

	Because the Preferred Stock can be converted at any time, the embedded derivative is classified as a current liability at March 31, 2014.

	The warrants associated with the Preferred Stock were also classified as equity, in accordance with FASB ASC 480-10-25. Therefore it is not necessary to bifurcate the warrants from the Preferred Stock.

	The Preferred Stock has a preference in liquidation that the holders of the Preferred Stock are to be paid out of assets available for distribution prior to holders of common stock. The Preferred Stockholders may cast the number of votes equal to the number of whole shares of common stock into which the shares of Preferred Stock can be converted.

	The conversion price of the Preferred Stock is currently $1.00 per share. There are no arrearages on cumulative dividends.

FAIR_VALUE_OF_FINANCIAL_INSTRU

FAIR VALUE OF FINANCIAL INSTRUMENT	3 Months Ended
FAIR VALUE OF FINANCIAL INSTRUMENT	Mar. 31, 2014
FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]	'
FAIR VALUE OF FINANCIAL INSTRUMENTS	'
	NOTE 8 - FAIR VALUE OF FINANCIAL INSTRUMENTS

	Derivative Liabilities

	For purposes of determining whether certain instruments are derivatives for accounting treatment, the Company follows the accounting standard that provides guidance for determining whether an equity-linked financial instrument, or embedded feature, is indexed to an entity's own stock. The standard applies to any freestanding financial instruments or embedded features that have the characteristics of a derivative, and to any freestanding financial instruments that are potentially settled in an entity's own common stock.

	The Company has identified the following liabilities that are measured at fair value on a recurring basis, summarized as follows:

	31-Mar-14	Level 1		Level 2		Level 3		Total

	Derivative liability related to fair value of beneficial conversion feature	$	-	$	3,834,200	$	-	$	3,834,200

	Total	$	-	$	3,834,200	$	-	$	3,834,200

	The following table details the approximate fair value measurements within the fair value hierarchy of the Company's derivative liabilities using Level 2 inputs:

		Total
	Balance at January 27, 2014	$	1,648,825
	Change in fair value of derivative liabilities		2,185,375

	Balance at March 31, 2014	$	3,834,200



	As of March 31, 2014, the beneficial conversion feature of the Preferred Stock is treated as an embedded derivative liability and changes in the fair value were recognized in earnings. The shares of Preferred Stock are convertible into shares of the Company's common stock, which did trade in an active securities market, therefore the embedded derivative liability was valued using the following market based inputs:

	Closing Trading Price of Common Stock	$	1.45
	Series A Preferred Stock Effective Conversion Price		0.69
	Intrinsic value of conversion option per share	$	0.76

	The Company has no assets that are measured at fair value on a recurring basis. There were no assets or liabilities measured at fair value on a non-recurring basis as of March 31, 2014 and December 31, 2013.

STOCKHOLDERS_EQUITY

STOCKHOLDERS' EQUITY	3 Months Ended
STOCKHOLDERS' EQUITY	Mar. 31, 2014
STOCKHOLDERS' EQUITY [Abstract]	'
STOCKHOLDERS' EQUITY	'
	NOTE 9 - STOCKHOLDERS' EQUITY

	During the first quarter of 2013, the Company entered into a private placement for shares of the Company's common stock. The shares were sold at a purchase price of $.75 per share. Through March 31, 2013, 1,133,334 shares were sold resulting in proceeds of $850,000. Issuance costs related to this private placement were $60,783.

	On April 15, 2013, the Company issued 26,521 restricted shares of the Company's common stock to five members of the Board of Directors that were valued at $49,071. In conjunction with this the five members of the Board also received in aggregate options to purchase 1,050,000 shares of the Company's common stock. These options were valued at $519,080, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.0%, risk free interest rate of .69% and expected option life of five years. The options expire five years from the date of issuance. Options granted will be expensed over the three year vesting term.

	On May 28, 2013, the Company entered into a Securities Purchase Agreement with accredited investors, pursuant to which we issued and sold an aggregate of 2,572,553 units at a purchase price of $1.80 per unit (the "Offering"), with each unit being comprised of one (1) share of the Company's common stock and a warrant to purchase one-half (0.5) of a share of common stock at an exercise price of $3.00 per share for a period of three years. On May 29, 2013, we issued and sold an additional 300,000 units pursuant to the Offering. The Company retained a placement agent in connection with the Offering. The Company paid the placement agent aggregate placement agent fees in the amount of $151,408 plus $155,118 as an expense allowance. In addition, the placement agent received three year warrants to purchase an aggregate of 287,255 shares of the Company's common stock at an exercise price of $1.80 per share (See Note 8-Stock Options and Warrants). Net proceeds of the Offering to the Company, after the expense allowance and other expenses, were approximately $4,836,157.


	During May 2013, options to purchase 750,000 shares of common stock were exercised at $0.04 per share, options to purchase 300,000 shares of common stock were exercised at $0.35 per share, and options to purchase 66,667 shares of common stock were exercised at $0.75, resulting in proceeds of $185,000.

	During May and June 2013, warrants to purchase 2,000,000 shares of common stock were exercised at $.04 per share and warrants to purchase 2,660,685 shares of common stock were exercised at $0.50 per share, resulting in proceeds of $1,410,342.

	During July and August 2013, warrants to purchase 34,500 shares of common stock were exercised at $.50 per share, resulting in proceeds of $17,250.

	In October 2013, an investor exercised 10,000 warrants to purchase common stock at $0.50 per share, resulting in proceeds of $5,000.

	In February 2014, the Company completed a private placement offering to holders of its outstanding warrants for the purchase of shares of common stock ("Warrantholders"), pursuant to which Warrantholders who were not directors or executive officers of the Company were given the opportunity to immediately exercise all outstanding vested warrants for cash in exchange for (i) the applicable shares of common stock underlying the exercised warrant and (ii) a new two-year warrant, granting rights to acquire an equivalent number of shares of common stock as issued pursuant to the exercised warrant(s), at an exercise price of $1.00 per share (each a "Replacement Warrant"). Pursuant to the offering, the Company received aggregate cash consideration of $2,521,143 from exercised warrants to purchase 5,042,287 shares of Company common stock.

	Modification of Warrants Issued in February 2012 Private Placement and Deemed Dividend
	Effective February 7, 2014, when the market price of our common stock was $1.18, we entered an exchange offering with certain investors in the 2011 to 2012 Private Placements to exercise their current warrants at $0.50 per share and receive a new warrant which would be convertible into the same number of common shares as the original warrant. The new warrant has an exercise price of $1.00. Many investors exercised the original warrants and received the new warrants. The Company has recognized a deemed dividend of $717,594 in the Statement of Operations for the three months ended March 31, 2014, attributable to the incremental fair value resulting from the modification of these warrants. The fair value of the new warrants was valued using the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 143.2%, risk free interest rate of 0.30% and expected option life approximating two years. The warrants expire two years from the date of issuance.

STOCK_OPTIONS_AND_WARRANTS

STOCK OPTIONS AND WARRANTS	3 Months Ended
STOCK OPTIONS AND WARRANTS	Mar. 31, 2014
STOCK OPTIONS AND WARRANTS [Abstract]	'
STOCK OPTIONS AND WARRANTS	'
	NOTE 10 - STOCK OPTIONS AND WARRANTS

	During 2008, the Board of Directors ("Board") of the Company adopted the 2008 Equity Incentive Plan ("2008 Plan") that was approved by the shareholders. Under the Plan, the Company is authorized to grant options to purchase up to 25,000,000 shares of common stock to any officer, other employee or director of, or any consultant or other independent contractor who provides services to the Company. The Plan is intended to permit stock options granted to employees under the 2008 Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended ("Incentive Stock Options"). All options granted under the 2008 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options ("Non-Statutory Stock Options"). As of March 31, 2014, options to purchase 14,023,330 shares of common stock have been issued and are unexercised, and 463,336 shares are available for grants under the 2008 Plan. Of the options to purchase 14,023,330 shares that have been issued and are unexercised, options to purchase 12,228,330 shares were granted to employees or persons who later became employees and options to purchase 1,795,000 shares were granted to non-employees.

	During 2013, the Board adopted the 2013 Equity Incentive Plan ("2013 Plan"), which was approved by stockholders at the 2013 annual meeting of stockholders. Under the 2013 Plan, the Company is authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards of up to an aggregate of 5,000,000 shares of common stock to any officer, employee, director or consultant. The 2013 Plan is intended to permit stock options granted to employees under the 2013 Plan to qualify as Incentive Stock Options. All options granted under the 2013 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be Non-Statutory Stock Options. As of March 31, 2014, under the 2013 Plan options to purchase 3,789,166 shares of common stock have been issued and are unexercised, and 1,210,834 shares of common stock remain available for grants under the 2013 Plan. Of the options to purchase 3,789,166 shares of common stock that have been issued and are unexercised, options to purchase 2,264,166 shares were granted to employees or persons who later became employees and 1,525,000 options to purchase shares were granted to non-employees.

	The 2008 Plan and 2013 Plan are administered by the Board or its compensation committee, which determines the persons to whom awards will be granted, the number of awards to be granted, and the specific terms of each grant, including the vesting thereof, subject to the terms of the applicable Plan.

	In connection with Incentive Stock Options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company).

	Prior to January 1, 2014, volatility in all instances presented is the Company's estimate of volatility that is based on the volatility of other public companies that are in closely related industries to the Company. Beginning January 1, 2014, volatility in all instances presented is the Company's estimate of volatility that is based on the volatility of the Company's stock history.


	Employee and Non-Employee Director Grants

	In January 2013, the Company issued eighteen employees options to purchase an aggregate of 260,000 shares of the Company's common stock at exercise prices between $0.99 and $1.05 per share. These options were valued at $62,662 fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 23.3% and 26.1%, risk free interest rate between .78% and .89% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

	In February 2013, the Company issued four employees options to purchase an aggregate of 760,000 shares of the Company's common stock at exercise prices between $1.07 and $1.21 per share. These options were valued at $199,843 fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 22.5% and 25.1%, risk free interest rate between .78% and .88% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

	In March 2013, the Company issued an employee options to purchase 2,500 shares of the Company's common stock at an exercise price of $1.36 per share. These options were valued at $728 fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.5%, risk free interest rate of .76% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

	In April 2013, the Company issued an employee options to purchase 5,000 shares of the Company's common stock at an exercise price of $1.67 per share. These options were valued at $933 fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.5%, risk free interest rate of .76% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

	In April 2013, the Company issued an employee options to purchase 200,000 shares of the Company's common stock at an exercise price of $1.56 per share. These options were valued at $74,159, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.3%, risk free interest rate of .76% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

	In May 2013, the Company issued two employees options to purchase an aggregate of 55,000 shares of the Company's common stock at an exercise price of $2.16 and $2.29 per share. These options were valued at $26,954, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5% to 25.3%, risk free interest rate of .84% to .85% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.


	In June 2013, the Company issued two employees options to purchase an aggregate of 250,000 shares of the Company's common stock at exercise prices of $2.40 and $2.92 per share. The vesting of 50,000 of these options is predicated on meeting certain milestones, therefore such options have not been valued. The remaining options were valued at $129,343, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.6% to 26.3%, risk free interest rate of 1.03% to 1.48% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

	In August 2013, the Company issued three employees options to purchase an aggregate of 210,000 shares of the Company's common stock at exercise prices of $2.00 and $2.35 per share. These options were valued at $124,392, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.2% to 30.3%, risk free interest rate of 1.38% to 1.61% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

	In September 2013, the Company issued two employees options to purchase an aggregate of 10,000 shares of the Company's common stock at an exercise price of $1.97 per share. These options were valued at $4,500, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 21.8%, risk free interest rate of 1.71% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

	In November 2013, the Company issued an employee options to purchase an aggregate of 10,000 shares of the Company's common stock at an exercise price of $1.04 per share. These options were valued at $2,613, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.6%, risk free interest rate of 1.31% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

	In December 2013, the Company issued four employees options to purchase an aggregate of 255,000 shares of the Company's common stock at an exercise price of $1.13 per share. These options were valued at $65,523, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.2%, risk free interest rate of 1.51% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

	In addition, in December 2013, an employee met a milestone relative to options to purchase 50,000 shares of the Company's common stock at an exercise price of $2.40 per share. These options were valued at $687, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.3%, risk free interest rate of 1.75% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.


	In January 2014, the Company issued 11 employees options to purchase an aggregate of 90,000 shares of the Company's common stock at an exercise price of $1.05 per share. These options were valued at $53,927, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 67.7%, risk free interest rate of 1.77% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

	In January 2014, the Company issued two employees options to purchase an aggregate of 35,000 shares of the Company's common stock at an exercise price of $1.05 per share. These options were valued at $27,806, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 67.7%, risk free interest rate of 3.01% and expected option life of ten years. The options expire ten years from the date of issuance. Options granted are expensed over the three year vesting term.

	In February 2014, the Company issued to one of our new board of directors members options to purchase an aggregate of 250,000 shares of the Company's common stock at an exercise price of $1.10 per share. These options were valued at $264,882, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 128.5%, risk free interest rate of 2.70% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

	In February 2014, the Company issued two employees options to purchase an aggregate of 20,000 shares of the Company's common stock at an exercise price of $1.18 per share. These options were valued at $21,048, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 142.1%, risk free interest rate of 1.47% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

	In February 2014, the Company extended warrants previously granted to two of its executive officers, which included 1,142,588 warrants exercisable at $0.04 per share and 100,000 warrants exercisable at $.75 per share for an additional two years. The increase in fair value of this term extension was $9,228 which was expensed during the three months ended March 31, 2014. The Company used the Black-Scholes option pricing model to calculate the increase in fair value, with the following assumptions: no dividend yield, expected volatility of 89.3% to 89.5%, risk free interest rate of 0.33%, and expected warrant life of 2 years.

	In March 2014, the Company issued to an employee options to purchase an aggregate of 100,000 shares of the Company's common stock at an exercise price of $1.43 per share. These options were valued at $136,454, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 122.6%, risk free interest rate of 2.73% and expected option life of ten years. The options expire ten years from the date of issuance. Options granted are expensed over the two year vesting term.


	Cumulatively and for the three months ended March 31, 2014 and 2013, the Company expensed $1,533,213, $239,104 and $133,698 relative to employee options/warrants granted. As of March 31, 2014, there was $1,594,574 of unrecognized compensation expense related to employee non-vested market-based share awards. A summary of stock option/warrant transactions for employees from January 1, 2013 to March 31, 2014 is as follows:

										Weighted Average
			Option/Warrants				Exercise			Exercise
			Shares				Price			Price
	Outstanding, December 31, 2012			17,258,644			$	0.04 to $1.82		$	0.48

	Granted			3,067,500				0.99 to 2.92			0.28
	Reclassified to non-employee			(235,000	)			0.65 to 2.30			(0.02	)
Exercised			(2,816,667	)			0.04 to 0.75			(0.01	)
Expired/terminated			(698,333	)			0.50 to 2.92			(0.01	)

Outstanding, December 31, 2013			16,576,144				0.04 to 2.40			0.74

Granted			495,000				1.05 to 1.43			0.03
Reclassified from non-employee			200,000				0.5			0.01
Exercised			(100,000	)			0.75			-
Expired/terminated			(460,003	)			0.65 to 2.16			(0.02	)

Outstanding, March 31, 2014			16,711,141			$	0.04 to $2.40		$	0.74

Exercisable, March 31, 2014			11,436,145			$	.04 to $2.30		$	0.49

Weighted Average Remaining Life,
Exercisable, March 31, 2014 (years)			1.7

Non-Employee Grants

In January 2013, the Company issued a consultant options to purchase 5,000 shares of the Company's common stock at an exercise price of $1.00 per share. These options were valued at $441 fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.3%, risk free interest rate of .78% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the term of the agreement.


In March 2013, the Company issued two consultants options to purchase 1,130,000 shares of the Company's common stock at exercise prices of $0.75 and $1.48 per share. 130,000 of these options vested immediately and were valued at $54,228, fair value. The vesting of the remaining 1 million options is predicated on meeting certain milestones, which were not met as of March 31, 2014. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.6% and 22.6%, risk free interest rate of .25% and .25%, and an expected option life of two to five years. The options expire two to five years from the date of issuance. The vested options granted, were expensed immediately. The remaining unvested options will be expensed when it is probable that the milestones will be achieved.

In March 2013, the Company issued to a consultant options to purchase 100,000 shares of the Company's common stock at exercise prices of $1.34 per share. These options vest over a one year period and were valued at $32,155 fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.8%, risk free interest rate of .8%, and an expected option life of 5 years. The options expire five years from the date of issuance. The options will be expensed over a one year period.

In April 2013, the Company issued a consultant options to purchase 100,000 shares of the Company's common stock at an exercise price of $2.04 per share. These options were valued at $44,603, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 26.5%, risk free interest rate of .68% and expected option life of five years. The options expire five years from the date of issuance. Options granted were expensed immediately.

In May 2013, the Company issued two consultants options to purchase 125,000 shares in the aggregate of the Company's common stock at exercise prices ranging from $3.05 to $3.28 per share. These options were valued at $51,869, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.1% to 23.2%, risk free interest rate of .29% to .31% and expected option life of two years. The options expire two years from the date of issuance. Options granted are expensed over the term of the agreement.

In May 2013, the Company, as part of the cost of the Company's Offering described in Note 7, issued the placement agent warrants to purchase 287,255 shares of the Company's common stock at an exercise price of $1.80 per share. These warrants were valued at $409,749, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 23.4% to 23.7%, risk free interest rate of .49% and expected option life of three years. The warrants expire three years from the date of issuance. The warrants granted were recorded as stock issuance costs and reduced additional paid in capital.

In July 2013, the Company issued two consultants options to purchase 100,000 shares in the aggregate of the Company's common stock at exercise prices ranging from $.75 to $2.61 per share. These options were valued at $124,338, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.8% to 26.6%, risk free interest rate of 1.35% to 1.66% and expected option life of five years. The options expire five years from the date of issuance. $124,338 was expensed immediately.


In September 2013, the Company issued a consultant options to purchase 100,000 shares of the Company's common stock at an exercise price of $1.17 per share. These options were valued at $26,208, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.1%, risk free interest rate of 1.39% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the term of the agreement, which is three years.

In October 2013, the Company issued a consultant options to purchase 20,000 shares of the Company's common stock at an exercise price of $1.06 per share. These options were valued at $6,132, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 30.2%, risk free interest rate of 1.33% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the term of the agreement, which is six months.

In November 2013, the Company issued a consultant options to purchase 100,000 shares of the Company's common stock at an exercise price of $1.04 per share. These options were valued at $26,128, fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.6%, risk free interest rate of 1.31% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the term of the agreement, which is one year.

On November 18, 2013, Company approved an amendment extending the term of outstanding warrants to purchase in the aggregate 8,931,505 shares of common stock of the Company at an exercise price of $0.50 per share. These warrants were scheduled to expire at various dates during 2013 and 2014 and were each extended for an additional one year period from the applicable original expiration date, with the new expiration dates ranging from December 20, 2014 to December 28, 2015. The Warrants were originally issued in private placements to accredited investors to raise additional capital during 2011 and 2012.The value of these warrant modifications was $6,540, computed by measuring the warrants immediately before and after such term extension. This was taken as a charge to operations in November 2013.

In February 2014, the Company completed a private placement offering to holders of its outstanding warrants for the purchase of shares of common stock as described in Note 7.

Cumulatively and for the three months ended March 31, 2014 and March 31, 2013, the Company expensed $1,893,237, $49,447 and $73,163 relative to non-employee options/warrants granted. As of March 31, 2014, there was $73,163 of unrecognized compensation expense related to such non-vested market-based share awards.


The following table summarizes non-employee stock options/warrants of the Company from January 1, 2013 to March 31, 2014 as follows:

									Weighted Average
		Option/Warrant				Exercise			Exercise
		Shares				Price			Price
Outstanding, December 31, 2012			16,531,438				0.35 to 2.30			0.63

Granted			2,048,750				0.01 to 3.28			0.18
Issued under Private Placement			1,723,533				1.80 to 3.00			0.3
Reclassified from employee			235,000				0.50 to 1.01			0.01
Exercised			(3,005,185	)			.35 to .50			-
Expired/Cancelled			(1,405,000	)			0.50 to 1.00			-

Outstanding, December 31, 2013			16,128,536				0.01 to 3.28			0.98

Granted			50,000				1.13			-
Issued under Private Placement			10,087,287				1			0.49
Reclassified to employee			(200,000	)			0.5			0.01
Exercised			(5,092,287	)			.35 to .50			-
Expired/Cancelled			(410,000	)			0.60 to 2.30			-

Outstanding, March 31, 2014			20,563,536			$	0.01 to $3.28		$	1.11

Exercisable, March 31, 2014			18,968,537			$	0.01 to $3.28		$	1.08

Weighted Average Remaining Life,
Exercisable, March 31, 2014 (years)			1.7

OPERATING_LEASES

OPERATING LEASES	3 Months Ended
	Mar. 31, 2014
OPERATING LEASES [Abstract]	'
OPERATING LEASES	'
	NOTE 11 - OPERATING LEASES

	For the three months ended March 31, 2014 and 2013, total rent expense under leases amounted to $138,843 and $55,648, respectively. At March 31, 2014, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:

	2014	$	293,696
	2015		300,194
	2016		200,696
		$	794,586

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
RELATED PARTY TRANSACTIONS	Mar. 31, 2014
RELATED PARTY TRANSACTIONS [Abstract]	'
RELATED PARTY TRANSACTIONS	'
	NOTE 12 - RELATED PARTY TRANSACTIONS

	During the three months ended March 31, 2013, a consultant owning more than 5% of the Company was paid for consulting and travel expenses to provide strategic advice to the Company. On January 1, 2013, the Company entered into an agreement with this consultant, whereby the Company would pay the consultant $12,500 per month beginning January 1, 2013 for a term of one year. In June 2013, this contract was terminated. Consulting fees paid for the three months ended March 31, 2013 were $25,000. Reimbursable business expenses of $2,946 and $23,566 were paid during the three months ended March 31, 2014 and 2013, respectively.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	3 Months Ended
SUBSEQUENT EVENTS	Mar. 31, 2014
SUBSEQUENT EVENTS [Abstract]	'
SUBSEQUENT EVENTS	'
	NOTE 13 - SUBSEQUENT EVENTS

	In April 2014, the Company issued options to purchase 55,000 shares of common stock to various employees at an exercise price of $1.27 per share.

	In April 2014, the Company, pursuant to the Purchase Agreement described in Note 7, issued in a private placement to certain accredited investors an additional 58,150 shares of the Series A Preferred Stock at an original issue price of $100 per share and warrants to purchase 5,815,000 shares of the Company's common stock for an aggregate purchase price of $5,815,000. Pursuant to the Purchase Agreement, the Company also granted piggyback registration rights to the holders of the Series A Preferred Stock and Warrants. The Purchase Agreement provides that the holders of the Series A Preferred Shares shall be entitled to nominate two directors of the Company. Dividends accrue at a rate of 8% and are cumulative.

	In April 2014, the Company entered into an agreement with a consulting firm to provide strategic consulting services. In connection with that agreement, the Company issued 300,000 restricted shares of common stock and an option to purchase 500,000 shares of the Company's common stock at $1.27 per share, which will vest subject to meeting certain milestones.

	On April 10, 2014, the Company was named in a law suit in superior court for the State of California from a former employee alleging wrongful termination and is asking for damages and legal fees to be paid. The Company intends to vigorously dispute the claims made by the former employee, while pursuing reasonable efforts to achieve a resolution of this matter. At this time it is not possible for us to provide any opinion as to any ultimate outcome or any definitive estimate of the amount of loss, if any, although we do not believe that any outcome will be significant to the Company's financial condition.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Mar. 31, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 915 for development stage entities. The accompanying unaudited financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions for Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States ("U.S. GAAP") for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The financial statements should be read in conjunction with the financial statements and notes included in the Company's Annual Report on form 10-K for the year ended December 31, 2013 as filed with the Securities and Exchange Commission (the "SEC"). Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ended December 31, 2014.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Comprehensive Income	'
	Comprehensive Income
	The Company follows FASB ASC 220 in reporting comprehensive income. Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income. The Company has one item of other comprehensive loss, consisting of a foreign translation adjustment.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The Company's financial instruments consist of accounts receivable, accounts payable and accrued expenses, embedded derivative and warrant liability. The carrying value of accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short maturities.

	The Company follows FASB ASC 820, Fair Value Measurements and Disclosures, and applies it to all assets and liabilities that are being measured and reported on a fair value basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

	Level 1: Quoted market prices in active markets for identical assets or liabilities

	Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data

	Level 3: Unobservable inputs that are not corroborated by market data

	The level in the fair value within which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.

Foreign Currency Translation	'
	Foreign Currency Translation
	The functional currency of operations outside the U.S. is British Pounds.
Concentration of Credit Risk Involving Cash	'
	Concentration of Credit Risk Involving Cash
	The Company may have deposits with a financial institution which at times exceed Federal Depository Insurance ("FDIC") coverage. The Company has not experienced any losses from maintaining cash accounts in excess of federally insured limits.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents.
Property and Equipment	'
	Property and Equipment
	Property and equipment is stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, principally three to seven years. Maintenance and repairs of property are charged to operations, and major improvements are capitalized. Upon retirement, sale, or other disposition of property and equipment, the costs and accumulated depreciation are eliminated from the accounts, and any resulting gain or loss is included in operations. Depreciation of property and equipment was $8,389 and $5,875 for the three months ended March 31, 2014 and 2013 and is included in general and administrative expenses.
Patents and trademarks	'
	Patents and Trademarks
	The Company has one issued patent with the United States Patent and Trademark Office ("USPTO"), entitled Systems and Method for Verifying the Age of an Internet User, and filed for nine provisional patents. Additionally, the Company has been issued two patents in Germany, entitled Virtual Piggy Bank and Parent Match, while the remaining patents in Germany are still pending. The Company also has patents pending in Australia, Brazil, Canada and Europe under the Patent Cooperation Treaty ("PCT"). Costs associated with the registration and legal defense of the patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents which were determined to be 20 years.
Long-Lived Assets	'
	Long-Lived Assets
	The Company evaluates the recoverability of its long-lived assets in accordance with FASB ASC 360 "Property, Plant, and Equipment." The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets are measured by a comparison of the carrying amount of an asset to future cash flows expected to be generated by the asset, undiscounted and without interest or independent appraisals. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the assets.
Revenue Recognition	'
	Revenue Recognition
	In accordance with Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 104, Revenue Recognition (Codified in FASB ASC 605), the Company will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, the Company will generally recognize revenue at the time of the sale of the associated product.
Income Taxes	'
	Income Taxes
	The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. Tax years from 2010 through 2013 remain subject to examination by major tax jurisdictions.
Stock-based Payments	'
	Stock-based Payments
	The Company accounts for stock-based compensation under the provisions of FASB ASC 718, Compensation-Stock Compensation which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC 505 -50, Equity-Based Payments to Non-Employees ("ASC 505-50"). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid-in capital in stockholders' equity over the applicable service periods.
Advertising Costs	'
	Advertising Costs
	Advertising costs are expensed as incurred. Advertising costs were $53,628 and $222,847 for the three months ended March 31, 2014 and 2013 and are included in sales and marketing expenses.
Research and Development Costs	'
	Research and Development Costs
	In accordance with FASB ASC 730, research and development costs are expensed when incurred. Research and development costs for the three months ended March 31, 2014 and 2013 were $852,744 and $454,378.
Loss Per Share	'
	Loss Per Share
	The Company follows FASB ASC 260 when reporting Earnings Per Share resulting in the presentation of basic and diluted earnings per share. Because the Company reported a net loss for the three months ended March 31, 2014 and 2013, common stock equivalents, including preferred stock, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same.
Start-up Costs	'
	Start-up Costs
	In accordance with FASB ASC 720, start-up costs are expensed as incurred.
Segment Information	'
	Segment Information
	The Company is organized and operates as one operating segment. In accordance with FASB ASC 280, Segment Reporting, the chief operating decision-maker has been identified as the Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company subject to Board approval. Since the Company operates in one segment and provides one group of similar products, all financial segment and product line information required by FASB ASC 280 can be found in the consolidated financial statements.
Recently Adopted Accounting Pronouncements	'

	Recently Adopted Accounting Pronouncements
	As of March 31, 2014 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company's financial statements.
Recently Issued Accounting Pronouncements Not Yet Adopted	'
	Recently Issued Accounting Pronouncements Not Yet Adopted
	As of March 31, 2014, there were no recently issued accounting standards not yet adopted which would have a material effect on the Company's financial statements.
Reclassifications	'
	Reclassifications
	Certain amounts in the 2013 and cumulative since inception statements of operations have been reclassified in order for them to be in conformity with the 2014 presentation.

FAIR_VALUE_OF_FINANCIAL_INSTRU1

FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)	3 Months Ended
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)	Mar. 31, 2014
FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]	'
Schedule Liabilities Measured at Fair Value on a Recurring Basis	'
	The Company has identified the following liabilities that are measured at fair value on a recurring basis, summarized as follows:

	31-Mar-14	Level 1		Level 2		Level 3		Total

	Derivative liability related to fair value of beneficial conversion feature	$	-	$	3,834,200	$	-	$	3,834,200

	Total	$	-	$	3,834,200	$	-	$	3,834,200
Schedule of Fair Value Measurement s of Derivative Liabilities Using Level 2 Inputs	'
	The following table details the approximate fair value measurements within the fair value hierarchy of the Company's derivative liabilities using Level 2 inputs:

		Total
	Balance at January 27, 2014	$	1,648,825
	Change in fair value of derivative liabilities		2,185,375

	Balance at March 31, 2014	$	3,834,200
Schedule of Market Based Inputs	'
	The shares of Preferred Stock are convertible into shares of the Company's common stock, which did trade in an active securities market, therefore the embedded derivative liability was valued using the following market based inputs:

	Closing Trading Price of Common Stock	$	1.45
	Series A Preferred Stock Effective Conversion Price		0.69
	Intrinsic value of conversion option per share	$	0.76

STOCK_OPTIONS_AND_WARRANTS_Tab

STOCK OPTIONS AND WARRANTS (Tables)	3 Months Ended
STOCK OPTIONS AND WARRANTS (Tables)	Mar. 31, 2014
STOCK OPTIONS AND WARRANTS [Abstract]	'
Summary of Stock Options and Warrant Transactions for Employees	'
	A summary of stock option/warrant transactions for employees from January 1, 2013 to March 31, 2014 is as follows:

							Weighted Average
		Option/Warrants			Exercise		Exercise
		Shares			Price		Price
	Outstanding, December 31, 2012		17,258,644		$	0.04 to $1.82	$	0.48

	Granted		3,067,500			0.99 to 2.92		0.28
	Reclassified to non-employee		(235,000	)		0.65 to 2.30		(0.02	)
	Exercised		(2,816,667	)		0.04 to 0.75		(0.01	)
	Expired/terminated		(698,333	)		0.50 to 2.92		(0.01	)

	Outstanding, December 31, 2013		16,576,144			0.04 to 2.40		0.74

	Granted		495,000			1.05 to 1.43		0.03
	Reclassified from non-employee		200,000			0.5		0.01
	Exercised		(100,000	)		0.75		-
	Expired/terminated		(460,003	)		0.65 to 2.16		(0.02	)

	Outstanding, March 31, 2014		16,711,141		$	0.04 to $2.40	$	0.74

	Exercisable, March 31, 2014		11,436,145		$	.04 to $2.30	$	0.49

	Weighted Average Remaining Life,
	Exercisable, March 31, 2014 (years)		1.7
Summary of Non-Employee Stock Options and Warrants	'
	The following table summarizes non-employee stock options/warrants of the Company from January 1, 2013 to March 31, 2014 as follows:

							Weighted Average
		Option/Warrant			Exercise		Exercise
		Shares			Price		Price
	Outstanding, December 31, 2012		16,531,438			0.35 to 2.30		0.63

	Granted		2,048,750			0.01 to 3.28		0.18
	Issued under Private Placement		1,723,533			1.80 to 3.00		0.3
	Reclassified from employee		235,000			0.50 to 1.01		0.01
	Exercised		(3,005,185	)		.35 to .50		-
	Expired/Cancelled		(1,405,000	)		0.50 to 1.00		-

	Outstanding, December 31, 2013		16,128,536			0.01 to 3.28		0.98

	Granted		50,000			1.13		-
	Issued under Private Placement		10,087,287			1		0.49
	Reclassified to employee		(200,000	)		0.5		0.01
	Exercised		(5,092,287	)		.35 to .50		-
	Expired/Cancelled		(410,000	)		0.60 to 2.30		-

	Outstanding, March 31, 2014		20,563,536		$	0.01 to $3.28	$	1.11

	Exercisable, March 31, 2014		18,968,537		$	0.01 to $3.28	$	1.08

	Weighted Average Remaining Life,
	Exercisable, March 31, 2014 (years)		1.7

OPERATING_LEASES_Tables

OPERATING LEASES (Tables)	3 Months Ended
OPERATING LEASES (Tables)	Mar. 31, 2014
OPERATING LEASES [Abstract]	'
Schedule of Future Minimum Rental Commitments Under Non-Cancelable Operating Lease Arrangements	'
	For the three months ended March 31, 2014 and 2013, total rent expense under leases amounted to $138,843 and $55,648, respectively. At March 31, 2014, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:

	2014	$	293,696
	2015		300,194
	2016		200,696
		$	794,586

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'	'
Estimated useful life of patents	'20 years	'
Advertising costs	$53,628	$222,847
Research and development expenses	852,744	454,378
Property, Plant and Equipment [Line Items]	'	'
Depreciation	$8,389	$5,875
Minimum [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Useful life	'3 years	'
Maximum [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Useful life	'7 years	'

GOING_CONCERN_Details

GOING CONCERN (Details) (USD $)	1 Months Ended	3 Months Ended		12 Months Ended	74 Months Ended
GOING CONCERN (Details) (USD $)	Apr. 30, 2014	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Mar. 31, 2014
MANAGEMENT PLANS [Abstract]	'	'	'	'	'
Amount raised from private placement	$5,800,000	$7,500,000	'	$8,300,000	'
Stock issuance costs	'	$170,165	$60,783	$400,000	$658,386

PATENTS_Details

PATENTS (Details) (USD $)	3 Months Ended		12 Months Ended
PATENTS (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]	'	'	'
Amortization period	'20 years	'	'
Patents [Member]	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'
Amortization period	'20 years	'	'
Unamortized capitalized patent costs	$784,152	'	$739,657
Amortization expense for patents	$10,129	$5,265	$28,541

NOTES_PAYABLE_Details

NOTES PAYABLE (Details) (USD $)	1 Months Ended	3 Months Ended
NOTES PAYABLE (Details) (USD $)	Dec. 27, 2013	Mar. 31, 2014	Mar. 31, 2013
Debt Instrument [Line Items]	'	'	'
Accreted interest on notes payable	'	$86,087	'
Sale proceeds amount	3,000,000	'	'
Agreement One [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Exercise price of warrants	0.01	'	'
Number of shares entitled by warrants	37,500	'	'
Note payable included per unit	500,000	'	'
Interest rate	10.00%	'	'
Agreement Two [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Exercise price of warrants	1	'	'
Number of shares entitled by warrants	50,000	'	'
Note payable included per unit	500,000	'	'
Interest rate	10.00%	'	'
Warrant [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Risk free interest rate	0.40%	'	'
Dividend yield	'	'	'
Pricing model used in calculation of grant-date fair value	'Black-Scholes option pricing model	'	'
Expected life	'2 years	'	'
Fair value of issued equity	$92,470	'	'
Expected volatility	22.20%	'	'

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
INCOME TAXES [Abstract]	'	'	'
Net operating loss carryforwards	'	'	$39.70
Income tax expense	'	'	'

LITIGATION_SETTLEMENT_Details

LITIGATION SETTLEMENT (Details) (USD $)	3 Months Ended
LITIGATION SETTLEMENT (Details) (USD $)	Mar. 31, 2013
LITIGATION SETTLEMENT [Abstract]	'
Cash payment for settlement	$450,000

CONVERTIBLE_PREFERRED_STOCK_De

CONVERTIBLE PREFERRED STOCK (Details) (USD $)	3 Months Ended			12 Months Ended			74 Months Ended	1 Months Ended	3 Months Ended
	Mar. 31, 2014	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2009	Mar. 31, 2014	Jan. 31, 2014	Mar. 31, 2014	Jan. 27, 2014
	Mar. 31, 2014	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2009	Mar. 31, 2014	Preferred Class A [Member]	Preferred Class A [Member]	Common Stock [Member]
Class of Stock [Line Items]	'	'	'	'	'	'	'	'	'	'
Issuance of stock, shares	'	49,000	'	'	'	'	'	50,450	'	'
Equity issuance, price per share	'	'	'	'	'	'	'	$100	'	'
Shares issuable upon exercise of warrants	'	'	'	'	'	'	'	'	'	5,045,000
Proceeds from issuance of preferred stock and warrants	$5,045,000	'	'	'	'	'	$5,045,000	'	'	'
Dividend rate	'	'	'	'	'	'	'	8.00%	'	'
Stock issuance costs	170,165	'	'	395,221	28,000	65,000	'	131,000	'	'
Purchase price of preferred stock and warrants	'	'	'	'	'	'	'	3,396,175	'	'
Benefical conversion feature	$1,648,825	'	'	'	'	'	$1,648,825	$1,648,825	$3,834,200	'
Conversion price	'	'	'	'	'	'	'	'	$1	'

FAIR_VALUE_OF_FINANCIAL_INSTRU2

FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Liabilities Measured at Fair Value on a Recurring Basis) (Details) (USD $)	Mar. 31, 2014	Jan. 27, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liability related to fair value of beneficial conversion feature	$3,834,200	'
Total	3,834,200	'
Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liability related to fair value of beneficial conversion feature	'	'
Total	'	'
Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liability related to fair value of beneficial conversion feature	3,834,200	1,648,825
Total	3,824,200	'
Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liability related to fair value of beneficial conversion feature	'	'
Total	'	'

FAIR_VALUE_OF_FINANCIAL_INSTRU3

FAIR VALUE OF FINANCIAL INSTRUMENTS (Fair Value MeasurementsWithin the Fair Value Hierarchy of the Company's Derivative Liabilities using Level 2 Inputs) (Details) (USD $)	3 Months Ended		74 Months Ended		2 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Level 1 [Member]	Level 2 [Member]	Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'	'	'	'
Balance at January 27, 2014	'	'	'	'	$1,648,825	'
Change in fair value of derivative liabilities	-2,185,375	'	-2,185,375	'	2,185,375	'
Balance at March 31, 2014	$3,834,200	'	$3,834,200	'	$3,834,200	'
Closing Trading Price of Common Stock	$1.45	'	$1.45	'	'	'
Series A Preferred Stock Effective Conversion Price	$0.69	'	'	'	'	'
Intrisic value of conversion option per share	$0.76	'	$0.76	'	'	'

STOCKHOLDERS_EQUITY_Narrative_

STOCKHOLDERS' EQUITY (Narrative) (Details) (USD $)

1 Months Ended

3 Months Ended

12 Months Ended

74 Months Ended

3 Months Ended

1 Months Ended

2 Months Ended

1 Months Ended

2 Months Ended

1 Months Ended

Apr. 30, 2014

Mar. 31, 2014

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Apr. 30, 2013

31-May-13

Jun. 30, 2013

31-May-13

Jun. 30, 2013

Aug. 31, 2013

Oct. 31, 2013

Feb. 28, 2014

Q1 2013 Issuance [Member]

April 15, 2013 Issuance [Member]

May 2013 Securities Purchase Agreement [Member]

May 2013 Options Exercised [Member]

May 2013 Options Exercised Transaction One [Member]

May 2013 Options Exercised Transaction Two [Member]

May 2013 Options Exercised Transaction Three [Member]

May and June 2013 Warrants Exercised [Member]

May and June 2013 Warrants Exercised Transaction One [Member]

July and August 2013 Warrants Exercised [Member]

October 2013 [Member]

February 2014 Private Placement [Member]

Modification of Warrants Issued in February 2012 [Member]

Restricted Stock [Member]

Warrant Type One [Member]

Warrant Type Two [Member]

Equity Issued [Line Items]

Equity issuance date

15-Apr-13

Issuance of stock, shares

49,000

26,521

Issuance of shares of common stock, value

$100,000

$49,071

Equity issuance, price or exercise price per security issued

$0.75

$1.80

$0.04

$0.35

$0.75

Warrants per unit

Number of shares entitled by warrants

0.5

287,255

5,042,287

Exercise price of warrants

1.8

0.5

0.04

0.5

Equity issuance, number securities issued for cash

1,133,334

2,572,553

Amount raised from private placement

5,800,000

7,500,000

8,300,000

850,000

4,836,157

Units issued

300,000

Exercised, shares

750,000

300,000

66,667

Proceeds from exercise of options

75,000

644,000

185,000

Warrants exercised

2,660,685

2,000,000

34,500

10,000

Proceeds from exercise of warrants

2,546,143

4,424,449

1,410,342

17,250

5,000

2,521,143

Stock issuance costs including commisions

170,165

60,783

400,000

658,386

60,783

Market price

$1.45

$1.18

Deemed dividend distribution in conjunction with warrant exchange offering

717,594

Options granted

1,050,000

Fair value of issued equity

519,080

Pricing model used in calculation of grant-date fair value

'Black-Scholes option pricing model

Expected life

'5 years

'2 years

Dividend yield

Expected volatility

29.00%

143.20%

Risk free interest rate

0.69%

0.30%

Vesting period

'3 years

Expiration period after issuance

'5 years

'2 years

Placement agent fees

151,408

Expense allowance

$155,118

STOCK_OPTIONS_AND_WARRANTS_Nar

STOCK OPTIONS AND WARRANTS (Narrative) (Details) (USD $)

11 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

Dec. 31, 2008

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

2008 Warrants Issued in Private Placement [Member]

2008 Equity Incentive Plan [Member]

2013 Equity Incentive Plan [Member]

Incentive Stock Options [Member]

Non-Statutory Stock Options [Member]

Options issued to employees [Member]

Options issued to non-employees [Member]

March 31, 2012 Options Issued to Consultants [Member]

Options issued to employees [Member]

Options issued to non-employees [Member]

Warrants to Purchase Common Stock [Member]

January 2013 Options Issued to Employees [Member]

February 2013 Options Issued to Employees [Member]

March 2013 Options Issued to Employees [Member]

April 2013 Options Issued To Employees [Member]

May 2013 Options Issued To Employees [Member]

June 2013 Options Issued To Employees [Member]

August 2013 Options Issued To Employees [Member]

September 2013 Options Issued To Employees [Member]

November 2013 Options Issued to Employee [Member]

December 2013 Options Issued to Employees [Member]

December 2013 Options Issued to Employee [Member]

April 2013 Options Issued To Employees [Member]

February 2014 Extension of Warrant Term [Member]

Warrants to Purchase Common Stock [Member]

January 2013 Options Issued to Consultants [Member]

March 2013 Options Issued To Consultants [Member]

April 2013 Options Issued To Consultants [Member]

March 2013 Options Issued To Consultant [Member]

May 2013 Options Issued To Consultants [Member]

May 2013 Options Issued for Private Placement [Member]

July 2013 Options Issued To Consultants [Member]

September 2013 Options Issued To Consultants [Member]

October 2013 Options Issued to Consultant [Member]

November 2013 Options Issued to Consultants [Member]

November 2013 Options Issued Amendment [Member]

January 2014 Option Issued to 11 Employees [Member]

January 2014 Options issued to 2 Employees [Member]

February 2014 Options Issued to New Members of Board of Directors [Member]

February 2014 Option Issued to Employees [Member]

February 2014 Extension of Warrant Term [Member]

March 2014 Option Issued to Employee [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

$.04 per Share Exercise Price Class [Member]

Warrants to Purchase Common Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Equity issuance date

18-Nov-13

Equity issuance date by month and year

'2013-01

'2013-02

'2013-03

'2013-04

'2013-05

'2013-06

'2013-08

'2013-09

'2013-11

'2013-12

'2013-04

'2013-01

'2013-03

'2013-04

'2013-03

'2013-05

'2013-07

'2013-09

'2013-10

'2013-11

'2014-01

'2014-02

'2014-03

Options authorized

25,000,000

5,000,000

Outstanding options

14,023,330

12,228,330

1,795,000

3,789,166

2,264,166

1,525,000

16,711,141

16,576,144

17,258,644

20,563,536

16,128,536

16,531,438

Options available to be issued

463,336

1,210,834

Options granted

260,000

760,000

2,500

200,000

55,000

210,000

10,000

255,000

50,000

5,000

130,000

100,000

125,000

287,255

100,000

20,000

100,000

90,000

35,000

250,000

20,000

100,000

Minimum option exercise price

$0.99

$1.07

$2.16

$2.40

$3.05

$0.75

Option exercise price

$1.36

$1.56

$1.97

$1.04

$1.13

$2.40

$1.67

$0.75

$2.04

$1.34

$1.80

$1.17

$1.06

$1.04

$1.05

$1.10

$1.18

$1.43

Maximum option exercise price

$1.05

$1.21

$2.29

$2.92

$2.35

$3.28

$2.61

Fair value of issued equity

$62,662

$199,843

$728

$74,159

$26,954

$129,343

$124,392

$4,500

$2,316

$655,523

$687

$933

$1,106

$54,228

$44,603

$32,155

$51,869

$409,749

$124,338

$26,208

$6,132

$26,128

$53,927

$27,806

$264,882

$21,048

$136,454

Pricing model used in calculation of grant-date fair value

'Black-Scholes option pricing model

Dividend yield

Expected volatility

22.50%

25.30%

21.80%

25.60%

22.20%

22.30%

22.50%

89.30%

89.50%

23.30%

22.60%

26.50%

25.80%

22.10%

30.20%

25.60%

67.70%

128.50%

142.10%

122.60%

Risk free interest rate

0.76%

1.71%

1.31%

1.51%

1.75%

0.76%

0.78%

0.25%

0.68%

0.80%

0.49%

1.39%

1.33%

1.31%

1.77%

3.01%

2.70%

1.47%

0.33%

2.73%

Expected life

'2 years

'5 years

'2 years

'3 years

'5 years

'10 years

'5 years

'2 years

'10 years

Options, expiration period

'5 years

'2 years

'3 years

'5 years

'10 years

'5 years

'10 years

Number of shares entitled by warrants

1,142,588

100,000

8,931,505

Exercise price of warrants

0.04

0.75

0.5

Warrants issued

14,950,002

Vesting period

'3 years

'5 years

'3 years

'2 years

Expected volatility, minimum

23.30%

22.50%

23.50%

23.60%

24.20%

23.10%

23.40%

23.80%

Expected volatility, maximum

26.10%

25.10%

25.30%

26.30%

30.30%

23.20%

23.70%

26.60%

Risk free rate, minimum

0.78%

0.84%

1.03%

1.38%

0.29%

1.35%

Risk free rate, maximum

0.89%

0.88%

0.85%

1.48%

1.61%

0.31%

1.66%

Share-based compensation

1,533,213

239,104

133,698

1,893,237

49,447

73,163

124,338

Unrecognized compensation expense

1,594,574

73,163

Incremental increase in value

9,228

Value of warrant modifications

$6,540

Aggregate options issued

250,000

1,130,000

Options issued, excluded from valuation

50,000

1,000,000

STOCK_OPTIONS_AND_WARRANTS_Inc

STOCK OPTIONS AND WARRANTS (Incentive Stock Option and Warrant Transactions for Employees) (Details) (Incentive Stock Options [Member], USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Option/Warrants Shares	'	'
Outstanding, shares, beginning of period	16,576,144	17,258,644
Granted, shares	495,000	3,067,500
Reclassified from (to) non-employee, shares	200,000	-235,000
Exercised, shares	-100,000	-2,816,667
Expired/terminated, shares	-460,003	-698,333
Outstanding, shares, end of period	16,711,141	16,576,144
Exercise Price	'	'
Reclassified from/to non-employee, exercise price	$0.50	'
Exercised, exercise price	$0.75	'
Weighted Average Exercise Price	'	'
Outstanding, weighted average exercise price, beginning of period	$0.74	$0.48
Granted, weighted average exercise price	$0.03	$0.28
Reclassified from/to non-employee, weighted average exercise price	$0.01	($0.02)
Exercised, weighted average exercise price	'	($0.01)
Expired/terminated, weighted average exercise price	($0.02)	($0.01)
Outstanding, weighted average exercise price, end of period	$0.74	$0.74
Exercisable, shares, September 30, 2013	11,436,145	'
Exercisable, weighted average exercise price, September 30, 2013	$0.49	'
Weighted Average Remaining Life, Exercisable, September 30, 2013 (years)	'1 year 8 months 12 days	'
Minimum [Member]	'	'
Exercise Price	'	'
Outstanding, exercise price, beginning of period	$0.04	$0.04
Granted, exercise price	$1.05	$0.99
Reclassified from/to non-employee, exercise price	'	$0.65
Exercised, exercise price	'	$0.04
Expired/terminated, exercise price	$0.65	$0.50
Outstanding, exercise price, end of period	$0.04	$0.04
Weighted Average Exercise Price	'	'
Exercisable, exercise price, September 30, 2013	$0.04	'
Maximum [Member]	'	'
Exercise Price	'	'
Outstanding, exercise price, beginning of period	$2.40	$1.82
Granted, exercise price	$1.43	$2.92
Reclassified from/to non-employee, exercise price	'	$2.30
Exercised, exercise price	'	$0.75
Expired/terminated, exercise price	$2.16	$2.92
Outstanding, exercise price, end of period	$2.40	$2.40
Weighted Average Exercise Price	'	'
Exercisable, exercise price, September 30, 2013	$2.30	'

STOCK_OPTIONS_AND_WARRANTS_Non

STOCK OPTIONS AND WARRANTS (Non Employee Stock Options and Warrants) (Details) (Non Statutory Stock Options [Member], USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Option/Warrant Shares	'	'
Outstanding, shares, beginning of period	16,128,536	16,531,438
Granted, shares	50,000	2,048,750
Issued under Private Placement, shares	10,087,287	1,723,533
Reclassified from (to) employee, shares	-200,000	235,000
Exercised, shares	-5,092,287	-3,005,185
Expired, shares	-410,000	-1,405,000
Outstanding, shares, end of period	20,563,536	16,128,536
Exercise Price	'	'
Granted, exercise price	$1.13	'
Issued under Private Placement, exercise price	$1	'
Reclassified from/to employee, exercise price	$0.50	'
Weighted Average Exercise Price	'	'
Outstanding, weighted average exercise price, beginning of period	$0.98	$0.63
Granted, weighted average exercise price	'	$0.18
Issued under Private Placement, weighted average exercise price	$0.49	$0.30
Reclassified from/to employee, weighted average exercise price	$0.01	$0.01
Exercised, weighted average exercise price	'	'
Expired, weighted average exercise price	'	'
Outstanding, weighted average exercise price, end of period	$1.11	$0.98
Exercisable, shares, September 30, 2013	18,968,537	'
Exercisable, weighted average exercise price, September 30, 2013	$1.08	'
Weighted Average Remaining Life, Exercisable, September 30, 2013 (years)	'1 year 8 months 12 days	'
Minimum [Member]	'	'
Exercise Price	'	'
Outstanding, exercise price, beginning of period	$0.01	$0.35
Granted, exercise price	'	$0.01
Issued under Private Placement, exercise price	'	$1.80
Reclassified from/to employee, exercise price	'	$0.50
Exercised, exercise price	$0.35	$0.35
Expired, exercise price	$0.60	$0.50
Outstanding, exercise price, end of period	$0.01	$0.01
Weighted Average Exercise Price	'	'
Exercisable, exercise price, September 30, 2013	$0.01	'
Maximum [Member]	'	'
Exercise Price	'	'
Outstanding, exercise price, beginning of period	$3.28	$2.30
Granted, exercise price	'	$3.28
Issued under Private Placement, exercise price	'	$3
Reclassified from/to employee, exercise price	'	$1.01
Exercised, exercise price	$0.50	$0.50
Expired, exercise price	$2.30	$1
Outstanding, exercise price, end of period	$3.28	$3.28
Weighted Average Exercise Price	'	'
Exercisable, exercise price, September 30, 2013	$3.28	'

OPERATING_LEASES_Details

OPERATING LEASES (Details) (USD $)	3 Months Ended
OPERATING LEASES (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013
OPERATING LEASES [Abstract]	'	'
Total rent expense under leases	$138,843	$55,648

OPERATING_LEASES_Schedule_of_N

OPERATING LEASES (Schedule of Non Cancelable Operating Lease Arrangements) (Details) (USD $)	Mar. 31, 2014
OPERATING LEASES [Abstract]	'
2014	$293,696
2015	300,194
2016	200,696
Total	$794,586

RELATED_PARTY_TRANSACTIONS_Det

RELATED PARTY TRANSACTIONS (Details) (Consultant and Beneficial Owner [Member], USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Consultant and Beneficial Owner [Member]	'	'
Related Party Transaction [Line Items]	'	'
Related party expenses	'	$25,000
Reimbursable business expenses	2,946	23,566
Monthly payment for consulting services per agreement	'	$12,500
Consulting agreement term	'1 year	'

SUBSEQUENT_EVENTS_Details

SUBSEQUENT EVENTS (Details) (USD $)	3 Months Ended		1 Months Ended
	Jun. 30, 2013	Jan. 27, 2014	Apr. 30, 2014	Apr. 30, 2014	Apr. 30, 2014	Apr. 30, 2014
		Common Stock [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]
				Consulting Firm [Member]	Series A Preferred Stock [Member]	Common Stock [Member]
Subsequent Event [Line Items]	'	'	'	'	'	'
Options granted	'	'	'	500,000	'	55,000
Equity issuance, price or exercise price per security issued	'	'	'	$1.27	$100	$1.27
Restricted shares issued	'	'	'	300,000	'	'
Issuance of stock, shares	49,000	'	'	'	58,150	'
Number of shares entitled by warrants	'	5,045,000	'	'	'	5,815,000
Purchase price of preferred stock and warrants	'	'	$5,815,000	'	'	'
Dividend rate	'	'	'	'	8.00%	'